Lillys reported share gains are impressive, but Novo remains a global GLP-1 incumbent with strong brand recognition and oral obesity exposure
For now, semaglutide remains a promising, yet supplementary, option for psoriasis management under the guidance of healthcare professionals
[4] [29] The GLP-1 component enhances insulin secretion, suppresses glucagon release, and slows gastric emptying, collectively reducing postprandial glucose excursions and promoting satiety
Nutritional supplementation of L-carnitine, the biologically active form of carnitine, is ameliorative for uremic patients, and can improve nerve conduction, neuropathic pain and immune function in diabetes patients while it is life-saving for patients suffering primary carnitine deficiency